Friday, 20 November 2026European Markets

MAAT PHARMA Stock Was Up By 10.75% Today

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(vianews) - the market ended the session with maat pharma (maat.pa) jumping 10.75% to €8.86 on wednesday while cac 40 rose 0.68% to €6,932.63.

maat pharma's last close was €8.00, 27.93% below its 52-week high of €11.10.

about maat pharma

maat pharma sa, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. its products pipeline includes maat013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; maat033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and maat03x for the treatment of solid tumors. the company was incorporated in 2014 and is headquartered in lyon, france.

earnings per share

as for profitability, maat pharma has a trailing twelve months eps of €-1.4.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -46.11%.

more news about maat pharma (maat.pa).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 1 Nov 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›